(888) 440-0954


A non-enzymatic two step catalytic reduction of methylglyoxal by nanostructured V2O5 modified electrode

Biosensors & bioelectronics, Vol. 103, Pages 143-150, 2017

PMID: 29291594

Methylglyoxal (MG) is a predominant precursor for advanced glycation end products (AGEs) due to its protein glycation reactions, which are the major causes of diabetic complications. MG is explored as a significant biomarker towards the prediction of diabetic complications.

Read More


Considering Genomic Research?

    Fields marked in * is mandatory to fill

    2024 © MedGenome • All Rights Reserved
    Request a Quote